Dermal and melanocortin research
MT-1
Lyophilized dermal or melanocortin research peptide
Free standard shipping to eligible destinations · estimated 7–11 business days after dispatch
Not a drug, food, dietary supplement, cosmetic, or medical product. Not for human or veterinary consumption. Not intended to diagnose, treat, cure, mitigate, or prevent disease. These materials have not been evaluated by the U.S. Food and Drug Administration.
Receive optional catalog and documentation updates. You can withdraw at any time.
Get catalog updatesProduct record
Specifications and documentation
- Product identity
- MT-1
- CAS number
- Available in product documentation
- Molecular weight
- Available in product documentation
- Purity / assay
- 98.8%-99.3%
- Forma
- Polvere liofilizzata
- Configuration
- 10 mg
- Archiviazione
- Conservare sigillato, freddo, asciutto e protetto dagli sbalzi di calore. Conferma lo stoccaggio specifico del prodotto all'arrivo.
- Certificato di analisi
- Available on request from support
Molecular class
13-residue alpha-MSH analog
Sequence / composition
An acetylated alpha-MSH-derived sequence containing norleucine and D-phenylalanine substitutions.
Research design note
Its construct is generally studied for MC1R-focused pigment biology rather than the broader receptor profile of Melanotan II.
External reading
Literature for context
Third-party sources describe their own research materials and methods. They do not validate a specific Azure catalog batch.
Keep comparing
Compare other catalog records.
Explore related research materials. These are not a combined-use recommendation.
-
Dermal
Public product preview
MT-2
Melanotan II is a melanocortin receptor research peptide connected to pigment, appetite, and central melanocortin-pathway literature.
-
Incretin research
Public product preview
AZ-GLP2(T)
Tirzepatide is a dual GIP / GLP-1 receptor agonist reference point in metabolic research and comparative incretin pharmacology.
-
Incretin research
Public product preview
GLP2(M)
Mazdutide sits in the GLP-1 / glucagon dual-agonist research lane, where interest centers on incretin signaling, energy expenditure, and metabolic markers.